PharmaNutra S.p.A. announced the signing of three new international trade agreements for the distribution of its SiderAL(R) and Cetilar(R) lines in the Republic of Indonesia, Kuwait and Mexico. As far as Indonesia is concerned, the new partner PT Pyridam Farma Tbk. will distribute two nutritional supplements containing Sucrosomial(R) Iron, SiderAL(R) F30 (PharmaNutra brand) and SiderAL(R) Gocce P (Junia Pharma brand). These products, the former intended for an adult target and the latter for the paediatric sector, will become part of the Pyridam Farma portfolio., As a matter of fact, the company has operated in the Indonesian pharmaceutical sector for more than 40 years andits production and marketing activities cover all 34 of the country's provinces, with a potential
usership of 275 million inhabitants. As regards Kuwait, the agreement concluded with PharmaLife Co., a company that distributes medical devices, food supplements, medical equipment and natural products is particularly relevant becausePharmaLife Co. will be placing five PharmaNutra products and one Junia Pharma product on the market, specifically: Cetilar(R) Cream, Cetilar(R) Patch, SiderAL(R) Folic 20 sticks, SiderAL(R) Folic 30 cps, SiderAL(R) Forte Int 20 cps and SiderAL(R) Gocce P. In Mexico, PharmaNutra has finalised a new partnership with the company SMS Pharma, whose core business focuses on developing national sales networks specialising in the distribution of pharmaceutical and health products. The contract with SMS Pharma will result, in the course of 2023, in the marketing of the nutritional supplements SiderAL(R) Forte 15mg 30 cps and SiderAL(R) Folic 21 mg 20 sticks (PharmaNutra), as well as SiderAL(R) Gocce P (Junia Pharma) throughout Mexico. With the conclusion of these new distribution agreements, the PharmaNutra Group can now count on 47 distributors in 70 countries across Europe, Asia, Latin America and Africa.